SCHEMBL21872806

SCHEMBL21872806

Cc1cc(C=N)c(NCC(C)(C)C#N)cc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21872420 0.84 — —
SCHEMBL21872491 0.82 IL1B (0.34) —
SCHEMBL24900934 0.77 — —
SCHEMBL21872459 0.77 — —
SCHEMBL21872399 0.71 — —
SCHEMBL21872448 0.70 — —
SCHEMBL21936271 0.69 — —
SCHEMBL27169591 0.66 LMNA (0.39) —
SCHEMBL21872871 0.61 — —
SCHEMBL21872860 0.61 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3632897-A1 NOVEL BIPHENYL COMPOUND OR SALT THEREOF Taiho Pharmaceutical Co., Ltd. (JP) 2020-04-08 — — EP disclosed
EP-3633380-A1 METHOD FOR PREDICTING THERAPEUTIC EFFECT OF LSD1 INHIBITOR BASED ON EXPRESSION OF INSM1 Taiho Pharmaceutical Co., Ltd. (JP) 2020-04-08 — — EP disclosed
Send feedback